Validation of Two Measures for Growth Hormone Deficiency in Children, the Treatment Related Impact Measure of Childhood Growth Hormone Deficiency (TRIM-CGHD) and the Treatment Burden Measure of Childhood Growth Hormone Deficiency (TB-CGHD)
Public ClinicalTrials.gov record NCT02580032. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study is conducted in Europe and the United States of America (USA). The aim of the study is to validate two measures for growth hormone deficiency in children, the Treatment Related Impact Measure of Childhood Growth Hormone Deficiency (TRIM-CGHD) and the Treatment Burden Measure of Childhood Growth Hormone Deficiency (TB-CGHD).
Study identification
- NCT ID
- NCT02580032
- Recruitment status
- Completed
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 252 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 4 Years to 13 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 5, 2015 (Actual)
- Primary completion
- May 14, 2018 (Actual)
- Completion
- May 14, 2018 (Actual)
- Last update posted
- Sep 25, 2020
2015 – 2018
United States locations
- U.S. sites
- 24
- U.S. states
- 16
- U.S. cities
- 23
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Novo Nordisk Investigational Site | Phoenix | Arizona | 85054 | — |
| Novo Nordisk Investigational Site | Centennial | Colorado | 80112 | — |
| Novo Nordisk Investigational Site | Wilmington | Delaware | 19803 | — |
| Novo Nordisk Investigational Site | Margate | Florida | 33063 | — |
| Novo Nordisk Investigational Site | Miami | Florida | 33155 | — |
| Novo Nordisk Investigational Site | Tallahassee | Florida | 32308 | — |
| Novo Nordisk Investigational Site | Atlanta | Georgia | 30342-1551 | — |
| Novo Nordisk Investigational Site | Wheaton | Illinois | 60187 | — |
| Novo Nordisk Investigational Site | Iowa City | Iowa | 52242 | — |
| Novo Nordisk Investigational Site | Louisville | Kentucky | 40202 | — |
| Novo Nordisk Investigational Site | Boston | Massachusetts | 02114 | — |
| Novo Nordisk Investigational Site | Saint Paul | Minnesota | 55102 | — |
| Novo Nordisk Investigational Site | St Louis | Missouri | 63017 | — |
| Novo Nordisk Investigational Site | Lebanon | New Hampshire | 03756-1000 | — |
| Novo Nordisk Investigational Site | Albany | New York | 12208-3412 | — |
| Novo Nordisk Investigational Site | Buffalo | New York | 14203 | — |
| Novo Nordisk Investigational Site | Mineola | New York | 11501 | — |
| Novo Nordisk Investigational Site | New York | New York | 10029 | — |
| Novo Nordisk Investigational Site | Spring Valley | New York | 10977 | — |
| Novo Nordisk Investigational Site | Cleveland | Ohio | 44195 | — |
| Novo Nordisk Investigational Site | Columbus | Ohio | 43235 | — |
| Novo Nordisk Investigational Site | Pittsburgh | Pennsylvania | 15218 | — |
| Novo Nordisk Investigational Site | Dallas | Texas | 75230 | — |
| Novo Nordisk Investigational Site | Dallas | Texas | 75235 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 4 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02580032, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 25, 2020 · Synced Oct 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02580032 live on ClinicalTrials.gov.